Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...
Patent
1977-03-11
1979-05-15
Curtis, Allen B.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Recombinant or stably-transformed bacterium encoding one or...
260404, 2604045, A01K 31135, C07C10100, C07C 8700
Patent
active
041548515
ABSTRACT:
This invention relates to novel .omega.-benzylamino alkanoic acids, to their salts with an organic or mineral base or with an organic or mineral acid. These alkanoic acids may be in a racemic form or resolved into their optically-active enantiomers.
They are produced by condensing an oxoalkanoic acid with a benzylamine under reducing conditions.
This invention also relates to .omega.-benzylamino alkanoic amides and to .omega.-benzylamino alkanoic acid esters.
They have therapeutical use, namely in the psychotherapeutical field. They are utilized in the form of pharmaceutical compositions.
REFERENCES:
patent: 3740439 (1973-06-01), Eichenberger
patent: 3758528 (1973-09-01), Malen et al.
patent: 3883586 (1975-05-01), Yokoyama et al.
Wagner et al., Synthetic Organic Chemistry, John Wiley & Sons, N.Y., N.Y., 1953, pp. 662-663.
Malen Charles
Poignant Jean-Claude
Roger Pierre
Behr Omri M.
Curtis Allen B.
Science Union et Cie, Societe Francaise de Recherche Medicale
LandOfFree
Benzylamino alkanoic acid derivatives, using compositions contai does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzylamino alkanoic acid derivatives, using compositions contai, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzylamino alkanoic acid derivatives, using compositions contai will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1097616